Diligence memo · auto-generated · as of July 2, 2026
Vaccine Technologies International Ltd.
Vaccine Technologies International Ltd. looks fair against its niche peers and is dormant on financing cadence.
Businessfiled
Vaccine Technologies International Ltd. operates in Biotechnology, based in GEORGE TOWN, GRAND CAYMAN.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Vaccine Technologies International Ltd. has raised $18M in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Series B (a $15M–$40M round).
Largest single filing: $18M on 2010-10-04.
Most recent recorded round closed around 2010-10-04.
Valuation (modeled)modeled
Provath models Vaccine Technologies International Ltd. at approximately $704M (range $36M–$2.7B). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Fair. Modeled value is 1.08× the median modeled value of Series B Biotechnology companies in 2010–2012 (48 peers) — value vs value, same stage and era. Within the normal band (108% of peer median) for its niche.
Financing rhythm & timingmixed
Last raise 15.7 yr ago; this sector typically re-raises about every 14 months.
Only one round on record and long silent — often defunct, acquired, or gone quiet.
Comparablesmixed
Capital scale ranks ahead of 66% of Biotechnology peers (4293 compared).
Modeled value ranks above 86% of those peers.
Closest niche peers: Redpoint Bio CORP, Cardiaq Valve Technologies Inc, Visterra, Inc., Celltex Therapeutics Corp, Crown Bioscience, Inc.
Peoplefiled
3 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.